Autoimmune Disease Diagnostics Market to achieve USD 14.8 Billion by 2020 on account of Hi
Autoimmune Disease Diagnostics Market – Global Indications and Diagnostic Methods Analysis and Forecast 2013-2020
According to a market research report published by iHealthcareAnalyst, Inc., Autoimmune Disease Diagnostics Market – Global Indications and Diagnostic Methods Analysis and Forecast 2013-2020, the global autoimmune disease diagnosticsmarketwas valued at USD 12.4 Billion in 2015 and is estimated to reach USD 14.8 Billion by 2020, at a CAGR of 3.6% from 2016 to 2020.
Browse the Autoimmune Disease Diagnostics Market – Global Indications and Diagnostic Methods Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/autoimmune-disease-diagnostics-market/
An autoimmune disease occurs when the body’s immune system begins to attack its own antigens. Autoimmune disease laboratory testing involves complete blood count with differential, comprehensive metabolic panel, inflammatory markers, antinuclear antibodies, autoantibodies, CRP, ESR, urinalysis, and flow cytometry. The autoimmune disease diagnosticsmarket report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on testing methods and their applications (Grave’s disease, Hashimoto's thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Type 1 diabetes, etc.) and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.
The global autoimmune disease diagnostics market is segmented as:
1. Diagnostic Test
1.1. Antinuclear Antibody Tests
1.2. Autoantibody Tests
1.3. C-Reactive Protein (CRP)
1.4. Complete Blood Count (CBC)
1.5. Comprehensive Metabolic Panel
1.6. Erythrocyte Sedimentation Rate (ESR)
2. Disease Type
2.1. Graves' Disease
2.2. Hashimoto's Thyroiditis
2.3. Multiple Sclerosis
2.4. Rheumatoid Arthritis
2.5. Systemic Lupus Erythematosus
2.6. Type 1 diabetes
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. Beckman Coulter, Inc.
4.3. bioMérieux SA
4.4. Bio-Rad Laboratories
4.5. F.Hoffmann-La Roche Ltd.
4.6. Inova Diagnostics, Inc.
4.7. Quest Diagnostics
4.9. SQI Diagnostics, Inc.
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Global Syndicate, custom and consulting grade healthcare market research reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
Jun 21, 2016